Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

"Marburg diagnostics the key" against lethal Angolan virus

This article was originally published in Clinica

Executive Summary

The United Nations has highlighted a need for "exceptionally precise diagnostics" to tackle the outbreak of Marburg haemorrhagic disease in Angola, amid fears that it might rapidly spread beyond its borders. Last week, the UN launched a $3.5m appeal to support work on this rare but highly lethal disease, saying that early diagnosis and isolation were vital. With a 90% fatality rate, Marburg ranks with the closely-related Ebola fever as being among the most lethal known to humans.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT054830

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel